<p><strong>Renal and hepatic impairment</strong>: Due to increased exposure in moderate renal and mild to&nbsp;moderate hepatic impairment, dosing recommendations to titrate according to individual tolerability should be closely followed<br />
<br />
<strong>Use in children</strong>: Rivastigmine is not recommended for use in children.</p>